Call us now :08071793621
Send Inquiry
Send InquiryGeftinat 250 mg tablet
Geftinat 250 mg tablet Specification
- Origin of Medicine
- Synthetic
- Salt Composition
- Gefitinib
- Pacakaging (Quantity Per Box)
- 30 tablets
- Drug Type
- Anti-cancer
- Ingredients
- Gefitinib 250 mg
- Physical Form
- Tablet
- Function
- Used in the treatment of non-small cell lung cancer
- Recommended For
- Patients with non-small cell lung cancer
- Dosage
- 250 mg per tablet as prescribed by a physician
- Dosage Guidelines
- Take orally once a day with or without food as directed by a healthcare professional
- Suitable For
- Adults
- Quantity
- 30 tablets per pack
- Storage Instructions
- Store in a cool dry place at a temperature below 30C. Keep away from light and moisture.
About Geftinat 250 mg tablet
Geftinat 250 mg Tablet is formulated with Gefitinib 250 mg as the active ingredient. It is a synthetic medicine primarily used in the treatment of non-small cell lung cancer. Each tablet contains a dosage of 250 mg and comes in a pack of 30 tablets. The tablets are recommended to be taken orally once a day as prescribed by a healthcare professional, either with or without food. This anti-cancer drug is suitable for adults and should be stored in a cool, dry place below 30C, away from light and moisture.
FAQs of Geftinat 250 mg tablet:
Q: What is the active ingredient in Geftinat 250 mg Tablet?
A: The active ingredient in Geftinat 250 mg Tablet is Gefitinib 250 mg.Q: What is the recommended dosage for this medicine?
A: The recommended dosage is 250 mg per tablet, to be taken orally once a day as directed by a physician.Q: Who is Geftinat 250 mg Tablet suitable for?
A: Geftinat 250 mg Tablet is suitable for adults.Q: How should Geftinat 250 mg Tablet be stored?
A: It should be stored in a cool, dry place below 30C, away from light and moisture.Q: What is the primary function of Geftinat 250 mg Tablet?
A: Geftinat 250 mg Tablet is primarily used in the treatment of non-small cell lung cancer.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Anti-Cancer Category
Posid 100 mg Injection
Salt Composition : Etoposide
Recommended For : Cancer patients as prescribed by oncologists
Function : Used in the treatment of cancers including testicular cancer and small cell lung cancer, Other
Ingredients : Etoposide 100 mg
Origin of Medicine : Synthetic
Drug Type : Other, Anticancer
Cytoplatin 10 mg Injection
Salt Composition : Cisplatin 10 mg
Recommended For : Cancer patients requiring chemotherapy
Function : Used in the treatment of various cancers such as testicular ovarian bladder and lung cancer., Other
Ingredients : Cisplatin
Origin of Medicine : Allopathic
Drug Type : Other, Chemotherapeutic/Anticancer
Biobin 100 mg Injection
Salt Composition : Vinblastine Sulfate
Recommended For : Cancer treatments such as lymphomas leukemias and other solid tumors.
Function : Used to kill or stop the growth of cancer cells., Other
Ingredients : Biobin 100 mg
Origin of Medicine : Synthetic
Drug Type : Injection
Prubicin 50 mg Injection
Salt Composition : Epirubicin Hydrochloride
Recommended For : Cancer patients
Function : Other, Used in the treatment of various types of cancer
Ingredients : Epirubicin Hydrochloride
Origin of Medicine : Synthetic
Drug Type : Injection
Send InquiryOur Products
- Alzheimers
- Anti-Cancer
- Anti-Fungal
- Anti-Viral
- Arthritis
- Blood Disorder
- Bone Disease
- Bone Marrow Disorder
- Bowel Disease
- Critical Care
- Gynaecology
- Liver Disease
- Lung Disease
- Macular Degeneration
- Multiple Sclerosis
- Nausea
- Nephrology
- Organ Transplant
- Orthostatic Hypotension
- Osteoporsis
- Psoriasis
- Skin Disorder
- Vaccines
- Pharmaceutical Injection
- Enoxaparin Sodium Medicine
- Oral Suspension
- Pharmaceutical Tablets
- Allopathic Medicine
229, Metro Mall, Bapa Sitaram Chawk, Opp. RAF Camp, S.P. Ring Road, Vastral, Ahmedabad - 382418, Gujarat, India
Dr. Harsh M Patel
(Director)
Mobile :08071793621
Send Inquiry
Send SMS
Developed and Managed by Infocom Network Private Limited.
